Vioxx (rofecoxib) for osteoarthritis and acute pain
June 1999
Merck is starting to promote Vioxx (rofecoxib) for osteoarthritis and acute pain.
It's a new COX-2 inhibitor...similar to Celebrex (celecoxib).
Vioxx and Celebrex are comparable to NSAIDs for reducing pain and inflammation...but the new drugs MIGHT cause fewer ulcers.
Practical advice for a better career, with unlimited access to CE
Pharmacy Technician's Letter includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 120+ CE courses, including the popular CE-in-the-Letter
- Helpful, in-depth Technician Tutorials
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote